SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock Balance Sheet
TSX-V:SVA - TSX Venture Exchange - CA81752F1062 - Common Stock - Currency: CAD
| MRQ (2022-1-31) | 2021 (2021-10-31) | 2020 (2020-10-31) | 2019 (2019-10-31) | 2018 (2018-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 27.18M | 27.87M | 3.95M | 1.80M | 1.74M | |||
| Cash Equivalents | N/A | N/A | N/A | 1.80M | 1.74M | |||
| Marketable Securities | N/A | N/A | 0.00 | 2.01M | 1.00M | |||
| Receivables | 350.00K | 450.00K | 510.00K | 740.00K | 470.00K | |||
| Other Current Assets | 340.00K | 4.20K | 150.00K | 780.00K | 100.00K | |||
| Total Current Assets | 27.86M | 28.33M | 4.61M | 5.32M | 3.32M | |||
| Non-Current Assets | ||||||||
| PPE Net | 760.00K | 560.00K | 200.00K | 250.00K | 290.00K | |||
| Intangibles | 670.00K | 720.00K | 920.00K | N/A | N/A | |||
| Other Non-Current Assets | 210.00K | 210.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.65M | 1.49M | 1.12M | 250.00K | 290.00K | |||
| TOTAL ASSETS | 29.51M | 29.82M | 5.73M | 5.57M | 3.61M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 120.00K | 120.00K | 0.00 | N/A | N/A | |||
| Accrued Expenses | N/A | 690.00K | 240.00K | 160.00K | N/A | |||
| Accounts Payable | N/A | 380.00K | 530.00K | 470.00K | N/A | |||
| Other Current Liabilities | N/A | 220.00K | 100.00K | 60.00K | 0.00 | |||
| Total Current Liabilities | 2.03M | 1.48M | 880.00K | 690.00K | 340.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 240.00K | 280.00K | 700.00K | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 240.00K | 270.00K | 700.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 2.27M | 1.75M | 1.58M | 690.00K | 340.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -56.65M | -51.06M | -46.23M | -41.36M | -37.44M | |||
| Additional Paid In Capital | 8.42M | 5.11M | 5.74M | 4.93M | 6.81M | |||
| Common Shares | 75.47M | 74.01M | 44.64M | 41.31M | 33.89M | |||
| Shares Outstanding | 262.26M | 261.13M | 208.26M | 195.95M | 159.37M | |||
| Tangible Book Value per Share | 0.10 | 0.10 | 0.02 | 0.02 | 0.02 | |||
| Total Shareholders' Equity | 27.24M | 28.07M | 4.14M | 4.88M | 3.26M | |||
| TOTAL LIABILITIES AND EQUITY | 29.51M | 29.82M | 5.73M | 5.57M | 3.61M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | 0.17 | N/A | N/A | |||
| Current Ratio | 13.72 | 19.14 | 5.24 | 7.71 | 9.76 | |||
| Return On Assets (ROA) | -37.07% | -23.37% | -92.84% | -71.27% | -102.49% | |||
| Return On Equity (ROE) | -40.16% | -24.83% | -128.50% | -81.35% | -113.50% | |||
All data in CAD , ROIC based on taxRate of 0.25